**Quibi, the Incredible Shrinking TV Set**\
`The mobile content app could be a place for innovation, but its first set of scripted shows looks like traditional television in miniature.`\
https://nytimes.com/2020/04/07/arts/television/quibi-shows.html?searchResultPosition=5

**Brazil Says China Will Help Ensure Medical Supplies for Coronavirus**\
`Brazil's Health Minister Luiz Henrique Mandetta said he spoke to China's ambassador to Brazil on Tuesday and the embassy will help ensure fulfillment of Chinese medical supplies to fight coronavirus.`\
https://nytimes.com/reuters/2020/04/07/world/americas/07reuters-health-coronavirus-brazil.html?searchResultPosition=6

**Jack Dorsey Pledges $1 Billion of His Square Stake for COVID-19 Relief Efforts**\
`Twitter Inc Chief Executive Officer Jack Dorsey on Tuesday pledged $1 billion of his stake in Square Inc, the payments processor that he co-founded and heads, to help fund relief efforts related to the coronavirus pandemic.`\
https://nytimes.com/reuters/2020/04/07/business/07reuters-health-coronavirus-jackdorsey.html?searchResultPosition=7

**Amazon Piloting Disinfectant Fog at New York Warehouse After Protests**\
`Amazon.com Inc told Reuters it is piloting the use of disinfectant fog starting on Tuesday at a warehouse in Staten Island, New York, within days of protests at the worksite over health concerns during the coronavirus pandemic.`\
https://nytimes.com/reuters/2020/04/07/business/07reuters-health-coronavirus-amazon-com-warehouse.html?searchResultPosition=8

**North Korea Testing, Quarantining for COVID-19, Still Says No Cases: WHO Representative**\
`North Korea, one of only a handful of countries not to have reported confirmed cases of COVID-19, has said that it continues testing and has more than 500 people in quarantine, the World Health Organization (WHO) told Reuters on Tuesday.`\
https://nytimes.com/reuters/2020/04/07/world/asia/07reuters-health-coronavirus-northkorea.html?searchResultPosition=9

**U.S. Regulators Delay Decision on Roche SMA Drug Risdiplam to Aug. 24**\
`U.S. regulators delayed a decision on Roche's spinal muscular atrophy drug risdiplam, the Swiss drugmaker said on Tuesday, after the company submitted more data in February on the medicine against the genetic muscle-wasting disease.`\
https://nytimes.com/reuters/2020/04/07/world/europe/07reuters-roche-risdiplam.html?searchResultPosition=10

